28.24USD-0.21%Mkt Cap: 1.38B $P/E: —1d ago
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The…
Industry Peers
Medical Instruments & Suppliesvs Medical Instruments & Supplies
P/B
Avg
1M Perf
Lower
Indicators:|
Key Statistics
Company
Market Cap1.38B $
Enterprise Value1.31B $
Revenue (TTM)101.66M $
Gross Profit62.12M $
Net Income (TTM)-4.59M $
Revenue/Share2.114 USD
Last Price28.24 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees155
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)85.58
PEG15.09
EV/EBITDA304.00
EV/Revenue12.92
P/S13.57
P/B3.70
EPS (TTM)-0.24
EPS (Forward)0.33
52W Range
17.8686% of range30.00
52W High30.00 USD
52W Low17.86 USD
Profitability
Gross Margin64.56%
Oper. Margin0.10%
EBITDA Margin4.25%
Profit Margin-4.78%
ROE-1.24%
ROA-1.13%
Growth
Revenue Growth24.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF20.11M $
CapEx (TTM)19.70M $
FCF Margin6.29%
FCF Yield0.46%
Net Debt-66.14M $
Net Debt/EBITDA-15.31
Balance Sheet
Debt/Equity0.05
Current Ratio7.30
Quick Ratio5.15
Book Value/Sh7.624 USD
Cash/Share1.658 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateJan 29, 2014
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)32.11 USD
Upside (mean)+13.7%
Target Range30.00 USD – 34.00 USD
$30.00+13.7% to mean$34.00
# Analysts9
Ownership
Shares Out.48.86M
Float42.68M
Insiders2.37%
Institutions104.51%
Short Interest
Short Ratio4.5d
Short % Float11.61%
Short % Out.7.42%
Shares Short3.63M
Short (prev mo.)3.78M
Technical
SMA 5024.03 (+17.5%)
SMA 20023.99 (+17.7%)
Beta1.97
S&P 52W Chg20.05%
Avg Vol (30d)958.59K
Avg Vol (10d)1.51M
Technical Indicators
RSI (14)63.0
MACD0.9467
MACD Signal0.8610
MACD Hist.+0.0858
BB Upper28.92 USD
BB Middle26.73 USD
BB Lower24.54 USD
BB Width16.39%
ATR (14)1.456 USD
Vol Ratio (20d)1.19x